Abstract
We studied the clinical features, laboratory and thyroid functions and thyrotropin (TSH)-receptor and thyroid-stimulation antibodies in 21 patients with atrophic auto-immune thyroiditis (AAT) and 48 patients with goitrous auto-immune thyroiditis (GAT) of childhood onset. The clinical features of patient with AAT were cessation of growth and obesity, while asymptomatic enlargement of the thyroid gland was the sole symptom in most patients with GAT. Although the ages at diagnosis were comparable in both groups, the estimated ages at onset were much lower in patients with AAT than in those with GAT. Patients with AAT exhibited more severe hypothyroidism when evaluated by serum thyroxine (T4), tri-iodothyronine (T3), TSH, cholesterol levels and basal metabolic rates. The 24h123I-thyroidal uptake was significantly lower in patients with AAT than in those with GAT. None of the 19 patients with AAT possessed TSH-binding inhibitor immunoglobulins (TBII). On the other hand, 3 of the 32 GAT patients tested, possessed weak to potent TBII activities. Three TBII-positive patients with GAT also possessed thyroid-stimulation blocking antibodies. These findings suggest that: 1. Pathogenesis of AAT in children whose onset of hypothyroidism was before puberty is not due to TSH-receptor blocking antibodies, which are often found in patients with AAT of postpubertal onset. 2. AAT in children is considered not to be due to the later stage of GAT. 3. Some patients with GAT possessed TSH-receptor blocking antibodies. The aetiology and pathogenesis of AAT in children have yet to be elucidated.
Similar content being viewed by others
Abbreviations
- AAT:
-
atrophic auto-immune thyroiditis
- GAT:
-
goitrous auto-immune thyroiditis
- ATA:
-
anti-thyroglobulin antibody
- AMA:
-
anti-microsomal antibody
- cAMP:
-
cyclic adenosine monophosphate
- TBII:
-
TSH-binding inhibitor immunoglobulins
- T4 :
-
thyroxine
- T3 :
-
tri-iodothyronine
- TSH:
-
thyrotropin
- TRH:
-
thyrotropin-releasing hormone
- TSBAb:
-
thyroid-stimulation blocking antibodies
References
Arikawa K, Ichikawa Y, Yoshida T, Shinozawa T, Homma M, Momotani N, Ito K (1985) Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action. J Clin Endocrinol Metab 60:953–959
Boden G, Yamaguchi YF, Shimoyama R, Shelmet JJ, Tappy L, Rezvani I, Owen DE (1988) Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes. J Clin Invest 81:1971–1978
Drexhage HA, Bottazzo GF, Bitensky L, Doniach D (1981) Thyroid growth-blocking antibodies in primary myxedema. Nature 289:594–596
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y, Mori T, Torizuka K (1978) Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab 46:734–739
Foley TP, Schubert WK, Marnell RT, McAdams AJ (1968) Chronic lymphocytic thyroiditis and juvenile myxedema in uniovular twins. J Pediatr 72:201–207
Gaag RDV, Drexhage HA, Dussault JH (1985) Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism. Lancet I:246–250
Geenberg AH, Czernichow P, Hung W, Chelley W, Winship T, Blizzard RM (1970) Juvenile chronic lymphocytic thyroiditis: clinical, laboratory and histological correlations. J Clin Endocrinol 30:293–301
Hayashi Y, Tamai H, Kiyohara K, Karibe C, Hirota Y, Fukino O, Matsuzuka F, Katayama S, Kuma K, Nagataki S (1984) A long-term follow-up study of patients with chronic lymphocytic thyroiditis-Especially concerning its histology. Folia Endocrinol (Jpn) 60:70–78
Iida Y, Konishi J, Kasagi K, Misaki T, Arai K, Tokuda Y, Torizuka K (1987) Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema. J Clin Endocrinol Metab 64:124–130
Inoue M, Taketani N, Sato T, Nakajima H (1975) High incidence of chronic lymphocytic thyroiditis in apparently healthy school children: epidemiological and clinical study. Endocrinol Jpn 22:483–489
Kasagi K, Konishi J, Iida Y, Ikekubo K, Mori T, Kuma K, Trizuka K (1982) A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3′, 5′-monophosphate increase. J Clin Endocrinol Metab 54:108–114
Kasagi K, Konishi J, Arai K, Misaki T, Iida Y, Endo K, Torizuka K (1986) A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J Clin Endocrinol Metab 62:855–862
Konishi J, Iida Y, Endo K, Misaki T, Nohara Y, Matsuura N, Mori T, Torizuka K (1973) Inhibition of thyrotropin-induced adenosine. 3′5′-monophosphate increase by immunoglobulins from patients with primary myxedema. J Clin Endocrinol Metab 57:544–549
Konishi J, Iida Y, Kasagi K, Misaki T, Nakashima T, Endo K, Mori T, Shinpo S, Nohara Y, Matsuura N, Torizuka K (1985) Primary myxedema with thyrotropin-binding inhibitor immunoglobulins clinical and laboratory findings in 15 patients. Ann Int Med 103:26–31
Maenpaa J, Raatikka M, Rasanen J, Taskinen E, Wager O (1985) Nature course of juvenile autoimmune thyroiditis. J Pediatr 107:898–904
Matsuura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Kojima H, Wataya K (1980) Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med 303:738–741
Murayama T, Ui M (1987) Possible involvement of a GTP-binding protein, the substrate of islet-activating protein, in receptor-mediated signaling responsible for cell proliferation. J Biol Chem 262:12463–12467
Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH (1975) Occurrence and national history of chronic lymphocytic thyroiditis in childhood. J Pediatr 86:675–682
Sklar CA, Qazi R, David R (1986) Juvenile auto-immune thyroiditis. Hormonal status at presentation and after long-term follow-up. Am J Dis Child 140:877–880
Southgate K, Creagh F, Teece M, Kingswood C, Smith BR (1984) A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol 20:539–543
Takasu N, Yamada T, Katakura M, Yamauchi K, Shimizu Y, Ishizuki Y (1987) Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3′, 5′-monophosphate responses/cell growth by immunoglobulins. J Clin Endocrinol Metab 65:239–245
Tokuda Y, Kasagi K, Iida Y, Hatabu H, Misaki T, Arai K, Endo K, Konishi J (1988) Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells from patients with goitrous and atrophic autoimmune thyroiditis. J Clin Endocrinol Metal 67:251–258
Vickery AL, Hamlin E jr (1961) Struma lymphomatosa (Hashimoto's thyroiditis). Observations on repeated biopsies in sixteen patients. N Engl J Med 264:226–229
Winter J, Ebertein WR, Bongiovanni AM (1966) The relationship of juvenile hypothyroidism to chronic lymphocytic thyroiditis. J Pediatr 69:709–718
Woolner LB, McConahey WM, Meahrs OH (1959) Struma lymphomatosa (Hashimoto's thyroiditis) and related thyroidal disorders. J Clin Endocrinol Metab 19:53–85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuura, N., Konishi, J., Yuri, K. et al. Comparison of atrophic and goitrous auto-immune thyroiditis in children: Clinical, laboratory and TSH-receptor antibody studies. Eur J Pediatr 149, 529–533 (1990). https://doi.org/10.1007/BF01957685
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957685